← All organizations

MedPacto, Inc.

For profitWebsite ↗

Also known as: MedPacto, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jan 31, 2023

Timeline

2010s

Jun 1, 2013
MedPacto, Inc.— Founded

Drugs by trial phase (8 distinct, 11 trials)

Phase 2 (8 own, 0 via acquisition)

Indications

Studied for

Recent trials (19)

NCT05588648Study chairPhase 1/Phase 2Jan 31, 2023
NCT05588648Lead sponsorPhase 1/Phase 2Jan 31, 2023
NCT06219733Lead sponsorPhase 2Nov 23, 2021
NCT06219733OfficialPhase 2Nov 23, 2021
NCT04515979Study directorPhase 2Nov 1, 2020
NCT04515979Lead sponsorPhase 2Nov 1, 2020
NCT04064190Lead sponsorPhase 2Dec 30, 2019
NCT03844750CollaboratorPhase 2May 1, 2019
NCT03732274Study directorPhase 1/Phase 2Dec 15, 2018
NCT03732274Lead sponsorPhase 1/Phase 2Dec 15, 2018
NCT03724851Study directorPhase 1/Phase 2Nov 30, 2018
NCT03724851Lead sponsorPhase 1/Phase 2Nov 30, 2018
NCT03698825Lead sponsorPhase 1Aug 20, 2018
NCT03698825Study directorPhase 1Aug 20, 2018
NCT03704675Study directorPhase 1Jul 25, 2018

Details

Founded: Suwon, KR Jun 1, 2013
Last known activity: Jan 31, 2023